Literature DB >> 18420308

PITX3 polymorphism is associated with early onset Parkinson's disease.

Olle Bergman1, Anna Håkansson, Lars Westberg, Kajsa Nordenström, Andrea Carmine Belin, Olof Sydow, Lars Olson, Björn Holmberg, Elias Eriksson, Hans Nissbrandt.   

Abstract

PITX3 is a transcription factor of importance for the differentiation and survival of midbrain dopaminergic neurons, the gene of which is disrupted in a putative mouse model for Parkinson's disease (PD). The A-allele of a HapMap tagging SNP (rs4919621) that was genotyped in a population of 361 PD patients, 69 of which had early onset, and in 333 controls, was significantly more common in PD patients with an early age of onset when compared either to controls (p=0.002) or to PD patients with late onset (p=0.001). In contrast, a previous finding suggesting a SNP (rs3758549) in the putative promoter region of the PITX3 gene to be associated with PD could not be replicated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420308     DOI: 10.1016/j.neurobiolaging.2008.03.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  23 in total

1.  Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease.

Authors:  Ziv Gan-Or; Anat Bar-Shira; Tanya Gurevich; Nir Giladi; Avi Orr-Urtreger
Journal:  Neurogenetics       Date:  2011-08-12       Impact factor: 2.660

2.  L-dopa reverses behavioral deficits in the Pitx3 mouse fetus.

Authors:  Gale A Kleven; Heather M Booth; Marco Voogd; April E Ronca
Journal:  Behav Neurosci       Date:  2014-08-25       Impact factor: 1.912

Review 3.  The role of transcription factor Pitx3 in dopamine neuron development and Parkinson's disease.

Authors:  Jia Li; John A Dani; Weidong Le
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

4.  Downregulation of DEC1 contributes to the neurotoxicity induced by MPP+ by suppressing PI3K/Akt/GSK3β pathway.

Authors:  Zhu Zhu; Yu-Wen Wang; Ding-Hao Ge; Ming Lu; Wei Liu; Jing Xiong; Gang Hu; Xiao-Ping Li; Jian Yang
Journal:  CNS Neurosci Ther       Date:  2017-07-21       Impact factor: 5.243

Review 5.  Genetics of anterior segment dysgenesis disorders.

Authors:  Linda M Reis; Elena V Semina
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

Review 6.  Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.

Authors:  Jesse V Veenvliet; Marten P Smidt
Journal:  Cell Mol Life Sci       Date:  2014-07-27       Impact factor: 9.261

7.  Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia.

Authors:  Matthew W Rice; Rosalinda C Roberts; Miguel Melendez-Ferro; Emma Perez-Costas
Journal:  Brain Struct Funct       Date:  2014-10-01       Impact factor: 3.270

8.  Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.

Authors:  Ariadna Laguna; Nicoletta Schintu; André Nobre; Alexandra Alvarsson; Nikolaos Volakakis; Jesper Kjaer Jacobsen; Marta Gómez-Galán; Elena Sopova; Eliza Joodmardi; Takashi Yoshitake; Qiaolin Deng; Jan Kehr; Johan Ericson; Per Svenningsson; Oleg Shupliakov; Thomas Perlmann
Journal:  Nat Neurosci       Date:  2015-04-27       Impact factor: 24.884

9.  Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.

Authors:  Malin von Otter; Sara Landgren; Staffan Nilsson; Dragana Celojevic; Petra Bergström; Anna Håkansson; Hans Nissbrandt; Marek Drozdzik; Monika Bialecka; Mateusz Kurzawski; Kaj Blennow; Michael Nilsson; Ola Hammarsten; Henrik Zetterberg
Journal:  BMC Med Genet       Date:  2010-03-02       Impact factor: 2.103

Review 10.  Cat-Map: putting cataract on the map.

Authors:  Alan Shiels; Thomas M Bennett; J Fielding Hejtmancik
Journal:  Mol Vis       Date:  2010-10-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.